

[our members]
C2I is home to over 25 biotechnology startups with the capability to provide more than 50 life science entrepreneurs a place to call home. Our residents have created over 100 highly skilled jobs and C2I had helped make an economic impact of 450M+ in funds raised in the Commonwealth.

Archimmune is an immuno-oncology platform company. Its first program is aimed at developing standardized antigen capturing nanoparticles that form a personalized, systemically-acting cancer vaccine in situ when injected intra-tumorally following radiotherapy. The second program exploits the ability of nanocarriers to simultaneously and bi-/tri-specifically engage with selected tumor and/or IO targets.

Fieldstone is a new biotechnology company bringing innovative remote-sensing technology to agriculture.

This is all I have for them: Anastasis Bio is a research-stage company founded in 2020 to develop therapeutics inspired by the work of professors Denise Montell of UC Santa Barbara and Shoukat Dedhar of The University of British Columbia. Our research focuses on targeting novel pathways involved in tumor cell survival, proliferation, and metastasis.


A biotechnology company intended to develop human antibodies as therapeutics for infectious disease.


MaxThera's strategy is to limit resistance emergence to combine the use of these new targets in biosynthetic pathways - essential for bacterial survival - with novel structural classes of compounds.